Watch for Duplicate Carbidopa/Levodopa Orders on Discharge Paperwork

July 2015

Rytary (rye-TAR-ee) is a new EXTENDED-release formulation of carbidopa/levodopa for Parkinson's disease.

Think of this new carbidopa/levodopa formulation as combining the fast onset of the IMMEDIATE-release (Sinemet, etc)...with the longer duration of the SUSTAINED-release (Sinemet CR, etc).

In general, expect Rytary to be used in patients admitted with advanced Parkinson's...especially in patients who have "off" time despite taking other carbidopa/levodopa products at least 4 times daily.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Learn More

Already a subscriber? Log in

Not sold to individuals

Medical Errors Help Develop Protocols to Reduce "Never Events"
Pulmonary Embolism Expect Less Use of IVC Filters With Anticoagulation
Dyslipidemia Consider Ezetimibe as a Statin Add-On
Antipsychotics Don't Treat Insomnia With Antipsychotics
Controlled Substances Recommend Naloxone at Discharge for Patients at Risk of Opioid Overdose
Med Safety Stop Gliptins in Patients Admitted With Heart Failure
Med Safety Treat Flozin Ketoacidosis With Your Diabetic Ketoacidosis Protocol
Probiotics Schedule a Probiotic At Least 2 Hours After an Antibiotic
New Drugs Watch for Duplicate Carbidopa/Levodopa Orders on Discharge Paperwork
Opioids Verify Fentanyl Patch Dose on Admission
Hepatitis C Don't Rely on Pentoxifylline for Alcoholic Hepatitis

Watch for Duplicate Carbidopa/Levodopa Orders on Discharge Paperwork

Get unlimited access through an Enterprise license

Table of Contents